Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proteasome inhibitor induced SIRT1 deacetylates GLI2 to enhance hedgehog signaling activity and drug resistance in multiple myeloma
Ying Xie, Jing Liu, Hongmei Jiang, et al.
Oncogene (2019) Vol. 39, Iss. 4, pp. 922-934
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies
Vivek Kumar, Mohit Vashishta, Lin Kong, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 177
Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies
Zhenduo Shi, Kun Pang, Zhuo‐Xun Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 102
Targeting NSD2-mediated SRC-3 liquid–liquid phase separation sensitizes bortezomib treatment in multiple myeloma
Jing Liu, Ying Xie, Jing Guo, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 61
Trending topics of SIRT1 in tumorigenicity
Liz M. Garcia‐Peterson, Xiaoling Li
Biochimica et Biophysica Acta (BBA) - General Subjects (2021) Vol. 1865, Iss. 9, pp. 129952-129952
Open Access | Times Cited: 55
ASPM Activates Hedgehog and Wnt Signaling to Promote Small Cell Lung Cancer Stemness and Progression
Li‐Hsin Cheng, Chung‐Chi Hsu, Hung‐Wen Tsai, et al.
Cancer Research (2023) Vol. 83, Iss. 6, pp. 830-844
Open Access | Times Cited: 22
All-trans retinoic acid improves NSD2-mediated RARα phase separation and efficacy of anti-CD38 CAR T-cell therapy in multiple myeloma
Ziyi Peng, Jingya Wang, Jing Guo, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 3, pp. e006325-e006325
Open Access | Times Cited: 14
Deacetylation induced nuclear condensation of HP1γ promotes multiple myeloma drug resistance
Xin Li, Sheng Wang, Ying Xie, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Role of Hedgehog and Hippo signaling pathways in cancer: A special focus on non-coding RNAs
Uttam Sharma, Hardeep Singh Tuli, Vivek Uttam, et al.
Pharmacological Research (2022) Vol. 186, pp. 106523-106523
Closed Access | Times Cited: 21
Epigenomic reprogramming via HRP2-MINA dictates response to proteasome inhibitors in multiple myeloma with t(4;14) translocation
Jingjing Wang, Xu Zhu, Lin Dang, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 4
Open Access | Times Cited: 19
Cigarette smoking extract induces mitochondrial dysfunction and apoptosis in HUVECs via the Sirt1-SHH axis
Weiming Wang, Gang Yuan, Guang Li, et al.
Human & Experimental Toxicology (2025) Vol. 44
Open Access
Hypoxia-induced CREB cooperates MMSET to modify chromatin and promote DKK1 expression in multiple myeloma
Yinyin Xu, Jing Guo, Jing Liu, et al.
Oncogene (2021) Vol. 40, Iss. 7, pp. 1231-1241
Open Access | Times Cited: 24
Gemcitabine therapeutically disrupts essential SIRT1-mediated p53 repression in atypical teratoid/rhabdoid tumors
Dennis S. Metselaar, Michaël H. Meel, Joshua R. Goulding, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 9, pp. 101700-101700
Open Access | Times Cited: 3
Targeting the ubiquitin pathway in lymphoid malignancies
Boheng Li, Pieter J.A. Eichhorn, Wee Joo Chng
Cancer Letters (2024) Vol. 594, pp. 216978-216978
Open Access | Times Cited: 3
DKK1 activates noncanonical NF-κB signaling via IL-6–induced CKAP4 receptor in multiple myeloma
Xin Li, Jingjing Wang, Shuai Zhu, et al.
Blood Advances (2021) Vol. 5, Iss. 18, pp. 3656-3667
Open Access | Times Cited: 19
The Wee1 kinase inhibitor MK1775 suppresses cell growth, attenuates stemness and synergises with bortezomib in multiple myeloma
Long Liang, Yanjuan He, Haiqin Wang, et al.
British Journal of Haematology (2020) Vol. 191, Iss. 1, pp. 62-76
Open Access | Times Cited: 17
Protective role of SIRT1-mediated Sonic Hedgehog signaling pathway in the preeclampsia rat models
Yi Huang, Xiaodan Zheng, Hui Li
Journal of Assisted Reproduction and Genetics (2021) Vol. 38, Iss. 7, pp. 1843-1851
Open Access | Times Cited: 15
CXCL10 Recruitment of γδ T Cells into the Hypoxic Bone Marrow Environment Leads to IL17 Expression and Multiple Myeloma Progression
Jingya Wang, Ziyi Peng, Jing Guo, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 10, pp. 1384-1399
Closed Access | Times Cited: 6
Targeting cancer hallmark vulnerabilities in hematologic malignancies by interfering with Hedgehog/GLI signaling
Peter W. Krenn, Fritz Aberger
Blood (2023) Vol. 142, Iss. 23, pp. 1945-1959
Open Access | Times Cited: 6
Promoting effects of MiR-135b on human multiple myeloma cells via regulation of the Wnt/β-catenin/Versican signaling pathway
Hong Chen, Yuan Zhao, Jiajia Zhang, et al.
Cytokine (2021) Vol. 142, pp. 155495-155495
Closed Access | Times Cited: 10
SIRT2 and SIRT3 expression correlates with redox imbalance and advanced clinical stage in patients with multiple myeloma
Alessandro Allegra, Vanessa Innao, Francesca Polito, et al.
Clinical Biochemistry (2021) Vol. 93, pp. 42-49
Closed Access | Times Cited: 10
Antagonistic Interaction between Histone Deacetylase Inhibitor: Cambinol and Cisplatin—An Isobolographic Analysis in Breast Cancer In Vitro Models
Marta Hałasa, Jarogniew J. Łuszczki, Magdalena Dmoszyńska‐Graniczka, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8573-8573
Open Access | Times Cited: 10
DKK1 suppresses WWP2 to enhance bortezomib resistance in multiple myeloma via regulating GLI2 ubiquitination
Qiguo Zhang, Wenyu Gong, Hongyan Wu, et al.
Carcinogenesis (2021) Vol. 42, Iss. 10, pp. 1223-1231
Closed Access | Times Cited: 10
Posttranslational modification of Aurora A‐NSD2 loop contributes to drug resistance in t(4;14) multiple myeloma
Hongmei Jiang, Yixuan Wang, Jingjing Wang, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 7
Novel Insights into the Initiation, Evolution, and Progression of Multiple Myeloma by Multi-Omics Investigation
Lixin Gong, Lugui Qiu, Mu Hao
Cancers (2024) Vol. 16, Iss. 3, pp. 498-498
Open Access | Times Cited: 1
Targeting the Interplay between HDACs and DNA Damage Repair for Myeloma Therapy
Μαρία Γκοτζαμανίδου, Elisavet Terpou, Nikolaos Kentepozidis, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10406-10406
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top